Atlas Trials

A Cut-off Value Study of N-terminal Brain Natriuretic Peptide (Chemiluminescence Method)

Clinical trial NCT06691477 · COMPLETED

Trial details

NCT number
NCT06691477
Sponsor
Beckman Coulter, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Heart FailureAcute Coronary Syndromes
Start date
2023-04-10
Primary completion
2024-09-18
Enrollment
1104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.